June 2022 - Volume 44 - Issue 3 : Therapeutic Drug Monitoring

Secondary Logo

Journal Logo

June 2022 - Volume 44 - Issue 3
pp: 359-473

High Tacrolimus Intrapatient Variability and Subtherapeutic Immunosuppression are Associated With Adverse Kidney Transplant Outcomes

Mendoza Rojas, Aleixandra; Hesselink, Dennis A.; van Besouw, Nicole M.; More

Therapeutic Drug Monitoring. 44(3):369-376, June 2022.

Drug–Drug Interactions With Cyclosporine in the Anti-Hepatitis C Viral PrOD Combination Regimen of Paritaprevir/Ritonavir–Ombitasvir and Dasabuvir in Organ Transplant Recipients With Severe Hepatic Fibrosis or Cirrhosis

Huang, Ying-Yu; Huang, Yu-Hsuan; Wu, Tsai-Hung; More

Therapeutic Drug Monitoring. 44(3):377-383, June 2022.

Development of a Sensitive and High-Throughput Assay for Simultaneous Quantification of 5 Tyrosine Kinase Inhibitors and 2 Active Metabolites in Human Plasma Using Ultra-high Performance Liquid Chromatography Coupled to Tandem Mass Spectrometry

Sumimoto, Takahiro; Nakahara, Ryosuke; Suzuki, Yosuke; More

Therapeutic Drug Monitoring. 44(3):419-429, June 2022.